StonvexLoading…
StonvexStonvexStonvexCore line items from CCLD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $120.50M | $110.84M | $117.06M | $138.83M |
Operating Income | $11.34M | $9.12M | $-47.12M | $6.61M |
Net Income | $10.80M | $7.85M | $-48.67M | $5.43M |
EPS (Diluted) | $0.10 | $-0.28 | $-4.11 | $-0.67 |
Total Assets | $87.60M | $71.61M | $77.83M | $136.17M |
Total Liabilities | $28.09M | $21.84M | $36.11M | $34.48M |
Cash & Equivalents | $3.12M | $5.14M | $3.33M | $12.30M |
Free Cash Flow OCF − CapEx | $23.78M | $18.95M | $12.40M | $18.56M |
Shares Outstanding | 42.44M | 16.26M | 15.88M | 15.23M |